Total Payments
$3,130
2024 Payments
$672.80
Companies
20
Transactions
66
Medicare Patients
2,155
Medicare Billing
$347,799
Payment Breakdown by Category
Food & Beverage$1,924 (61.5%)
Travel$1,206 (38.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,924 | 63 | 61.5% |
| Travel and Lodging | $1,206 | 3 | 38.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $974.91 | 3 | $0 (2017) |
| Noah Medical Corporation | $638.36 | 2 | $0 (2024) |
| Veran Medical Technologies, Inc. | $492.21 | 3 | $0 (2021) |
| GlaxoSmithKline, LLC. | $328.06 | 19 | $0 (2020) |
| Actelion Pharmaceuticals US, Inc. | $177.40 | 13 | $0 (2019) |
| Insmed, Inc. | $114.98 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $100.57 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $53.36 | 4 | $0 (2020) |
| Gilead Sciences, Inc. | $44.89 | 3 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $31.20 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $672.80 | 5 | Noah Medical Corporation ($605.21) |
| 2023 | $33.15 | 1 | Noah Medical Corporation ($33.15) |
| 2021 | $49.75 | 2 | Veran Medical Technologies, Inc. ($31.31) |
| 2020 | $34.94 | 2 | GlaxoSmithKline, LLC. ($19.61) |
| 2019 | $195.06 | 6 | Insmed, Inc. ($114.98) |
| 2018 | $623.90 | 13 | Veran Medical Technologies, Inc. ($460.90) |
| 2017 | $1,520 | 37 | Covidien LP ($974.91) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Life Molecular Imaging Ltd | NEURACEQ (Drug) | Food and Beverage | Cash or cash equivalent | $13.00 | General |
| Category: Diagnostic Tracer | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Immunology | ||||||
| 06/20/2024 | Olympus America Inc. | Spiration Valve System (Device) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Endotherapy | ||||||
| 05/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: RESPIRATORY | ||||||
| 04/14/2024 | Noah Medical Corporation | GALAXY (Device) | Food and Beverage | Cash or cash equivalent | $605.21 | General |
| Category: Bronchoscope (Flexible Or Rigid) And Accessories | ||||||
| 11/09/2023 | Noah Medical Corporation | — | Food and Beverage | Cash or cash equivalent | $33.15 | General |
| Category: Pulmonary Disease | ||||||
| 02/02/2021 | Veran Medical Technologies, Inc. | SPiN Thoracic Navigation System, 120V, 60Hz (Device) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: Respiratory | ||||||
| 01/26/2021 | Medtronic, Inc. | Edge Navigation (Device) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Interventional Lung Solutions | ||||||
| 02/28/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: RESPIRATORY | ||||||
| 01/24/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/11/2019 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Cardiology | ||||||
| 09/20/2019 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Cardiology | ||||||
| 04/12/2019 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardiology | ||||||
| 04/04/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $114.98 | General |
| Category: Respiratory | ||||||
| 02/18/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2019 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Cardiology | ||||||
| 12/14/2018 | Actelion Pharmaceuticals US, Inc. | OPSUMIT MACITENTAN (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: CARDIOVASCULAR DISORDERS | ||||||
| 11/30/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.70 | General |
| 10/26/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.40 | General |
| 09/11/2018 | Veran Medical Technologies, Inc. | Spin (Device) | Travel and Lodging | Cash or cash equivalent | $261.82 | General |
| Category: Pulmonology | ||||||
| 09/11/2018 | Veran Medical Technologies, Inc. | Spin (Device) | Food and Beverage | Cash or cash equivalent | $199.08 | General |
| Category: Pulmonology | ||||||
| 08/31/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/25/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/19/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: RESPIRATORY | ||||||
| 04/13/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 452 | 792 | $211,422 | $72,080 |
| 2022 | 9 | 497 | 860 | $114,672 | $47,578 |
| 2021 | 15 | 864 | 6,487 | $381,715 | $195,187 |
| 2020 | 10 | 342 | 589 | $71,987 | $32,954 |
Total Patients
2,155
Total Services
8,728
Medicare Billing
$347,799
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 78 | 164 | $104,963 | $26,603 | 25.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 144 | 356 | $47,362 | $22,123 | 46.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 82 | 86 | $22,862 | $8,633 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 51 | $10,488 | $5,040 | 48.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 49 | $9,251 | $4,549 | 49.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $3,298 | $1,705 | 51.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,680 | $1,443 | 39.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 23 | 24 | $2,020 | $942.83 | 46.7% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 11 | 11 | $6,208 | $727.35 | 11.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 15 | 15 | $1,290 | $313.80 | 24.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 156 | 489 | $63,536 | $26,987 | 42.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 76 | 81 | $21,098 | $8,128 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 60 | $11,412 | $5,091 | 44.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $6,547 | $2,637 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 35 | $4,178 | $2,014 | 48.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 46 | 54 | $4,410 | $1,584 | 35.9% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 51 | 51 | $1,078 | $440.27 | 40.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 20 | 20 | $1,678 | $358.85 | 21.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 52 | 52 | $735.00 | $337.62 | 45.9% |
| J2182 | Injection, mepolizumab, 1 mg | Office | 2021 | 17 | 5,100 | $198,900 | $116,444 | 58.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 150 | 513 | $64,604 | $28,297 | 43.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 93 | 139 | $25,658 | $13,251 | 51.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 121 | 158 | $18,324 | $10,145 | 55.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 77 | 80 | $20,168 | $8,434 | 41.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 52 | 52 | $15,852 | $5,913 | 37.3% |
About Dr. Ashley Ferraro, DO
Dr. Ashley Ferraro, DO is a Pulmonary Disease healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912917139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashley Ferraro, DO has received a total of $3,130 in payments from pharmaceutical and medical device companies, with $672.80 received in 2024. These payments were reported across 66 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,924).
As a Medicare-enrolled provider, Ferraro has provided services to 2,155 Medicare beneficiaries, totaling 8,728 services with total Medicare billing of $347,799. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Shreveport, LA
- Active Since 08/09/2006
- Last Updated 09/10/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1912917139
Products in Payments
- superDimension (Device) $974.91
- GALAXY (Device) $605.21
- Spin (Device) $460.90
- Arikayce (Drug) $114.98
- OPSUMIT MACITENTAN (Drug) $112.06
- ANORO (Drug) $80.61
- BREO (Drug) $74.39
- OPSUMIT (Drug) $65.34
- XARELTO (Drug) $53.36
- STIOLTO RESPIMAT (Drug) $40.29
- ELIQUIS (Drug) $33.93
- SPiN Thoracic Navigation System, 120V, 60Hz (Device) $31.31
- XIFAXAN (Drug) $31.20
- ZERBAXA (Drug) $26.23
- Spiration Valve System (Device) $20.72
- OFEV (Drug) $19.61
- TRELEGY ELLIPTA (Drug) $19.61
- NUCALA (Biological) $18.50
- Edge Navigation (Device) $18.44
- Prolastin-C (Biological) $16.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Shreveport
Dr. Kirit Patel, M.d, M.D
Pulmonary Disease — Payments: $113,159
Pulmonary Disease $113,159
Ammar Alqaid, Md, MD
Pulmonary Disease — Payments: $16,562
Pulmonary Disease $16,562
Sukhmani Boparai, Md, MD
Pulmonary Disease — Payments: $2,297
Pulmonary Disease $2,297
Kimberly Jones, M.d, M.D
Pulmonary Disease — Payments: $1,715
Pulmonary Disease $1,715
Indira Sastry, M.d, M.D
Pulmonary Disease — Payments: $1,235
Pulmonary Disease $1,235
Randy Bryn, Md, MD
Pulmonary Disease — Payments: $572.77
Pulmonary Disease $572.77